Abstract
From 1965 to 1970 mesothelioma was an extreme rarity in the medical wards. It became more common in the 1990s, an increase that was documented by the Health and Safety Executive in the UK. At that time, there were already some published series on extirpative surgery for mesothelioma. However, results were difficult to interpret due to variation in protocols and no control data. The observations and concerns leading to the establishment of the Mesothelioma and Radical Surgery (MARS) trial summarized here reflect a personal experience.
Keywords: Mesothelioma, prognosis, thoracic surgery.
Related Journals
Current Dentistry
Current Traditional Medicine
Adolescent Psychiatry
New Emirates Medical Journal
Current Radiopharmaceuticals
Recent Patents on Anti-Cancer Drug Discovery
Current Medicinal Chemistry - Anti-Cancer Agents
Current Cancer Therapy Reviews
Clinical Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Recent Advances in Anesthesiology
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents